2023
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
Filardi B, Monteiro V, Schwartzmann P, do Prado Martins V, Zucca L, Baiocchi G, Malik A, Silva J, Hahn A, Chen N, Pham K, Pérez-Then E, Miric M, Brache V, Cochon L, Larocca R, Della Rosa Mendez R, Silveira D, Pinto A, Croda J, Yildirim I, Omer S, Ko A, Vermund S, Grubaugh N, Iwasaki A, Lucas C, Initiative Y, Vogels C, Breban M, Koch T, Chaguza C, Tikhonova I, Castaldi C, Mane S, De Kumar B, Ferguson D, Kerantzas N, Peaper D, Landry M, Schulz W. Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose. Science Translational Medicine 2023, 15: eade6023. PMID: 36791210, DOI: 10.1126/scitranslmed.ade6023.Peer-Reviewed Original ResearchConceptsBooster doseAntibody responseNeutralization titersVirus-specific IgG titersOlder adultsAntiviral humoral immunityPlasma antibody responsesHigh-risk populationSARS-CoV-2 spikeYears of ageAge-dependent impairmentHeterologous regimensBooster dosesBooster vaccineCoronaVac vaccineIgG titersProtective immunityHumoral immunityHumoral responseCoronaVacOmicron waveBooster strategyAge groupsEarly controlVaccine
2020
Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review
Davlidova S, Haley-Johnson Z, Nyhan K, Farooq A, Vermund SH, Ali S. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review. International Journal Of Infectious Diseases 2020, 104: 510-525. PMID: 33385583, PMCID: PMC11094609, DOI: 10.1016/j.ijid.2020.12.068.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis B virusHepatitis C virusPrevalence of HIVHigh prevalenceSystematic reviewSubstantial public health threatHigh-risk groupHigh-risk populationNational surveillance reportsPublic health threatHBV prevalenceHCV prevalenceHIV prevalenceImmunodeficiency virusC virusLanguage restrictionsB virusPrevalenceSurveillance reportsHealth threatVirusPublication datePWIDEMBASETransmission of HIV and HCV within Former Soviet Union Countries
Aibekova L, Bexeitova A, Aldabergenova A, Hortelano G, Ge Z, Yi F, Shao Y, DeHovitz J, Vermund SH, Ali S. Transmission of HIV and HCV within Former Soviet Union Countries. Canadian Journal Of Gastroenterology And Hepatology 2020, 2020: 9701920. PMID: 32733822, PMCID: PMC7378597, DOI: 10.1155/2020/9701920.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis C virusBlood-borne infectionsTransmission of HIVInjection drug useBlood-borne virusesHigh-risk populationInjection drug usersHarm reduction effortsOrigin of infectionImmunodeficiency virusC virusFSU countriesDrug usersDrug useHIV sequencesInfectionFormer Soviet Union countriesSoviet Union countriesVirusMajor populationPopulation
2008
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors
Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International Journal Of Infectious Diseases 2008, 13: 9-19. PMID: 18835208, PMCID: PMC2651958, DOI: 10.1016/j.ijid.2008.06.019.Peer-Reviewed Original ResearchConceptsHepatitis C antibodyHepatitis CHepatitis BRisk factorsAntigen prevalenceHigh burdenC antibodyActive hepatitis BChronic hepatitis CBlood product transfusionHigh-risk subgroupsHigh-risk populationNational prevalence estimatesMode of transmissionWorld's highest burdenUnsafe bloodChronic hepatitisProduct transfusionLiver failurePediatric populationHigh prevalenceHepatocellular carcinomaNeedle usePrevalence estimatesHealthy adults
2007
HIV Voluntary Counseling and Testing among Injection Drug Users in South China: A Study of a Non-Government Organization Based Program
Chen HT, Liang S, Liao Q, Wang S, Schumacher JE, Creger TN, Wilson CM, Dong B, Vermund SH. HIV Voluntary Counseling and Testing among Injection Drug Users in South China: A Study of a Non-Government Organization Based Program. AIDS And Behavior 2007, 11: 778-788. PMID: 17347877, DOI: 10.1007/s10461-007-9215-x.Peer-Reviewed Original ResearchConceptsHIV voluntary counselingVCT programmeVoluntary counselingDrug usersHIV prevention servicesHigh-risk populationInjection drug usersHIV prevalence ratesRapid HIVFemale IDUsHIV knowledgeSafe drugStudy populationGovernment health agenciesPrevalence ratesPrevention servicesSex practicesHealth agenciesIDUsRapid testVCTCounselingGreat needHIVPopulation
2002
HIV-1 and HIV-2 Seroprevalence and Risk Factors Among Hospital Outpatients in the Eastern Region of Ghana, West Africa.
Chang LW, Osei-Kwasi M, Boakye D, Aidoo S, Hagy A, Curran JW, Vermund SH. HIV-1 and HIV-2 Seroprevalence and Risk Factors Among Hospital Outpatients in the Eastern Region of Ghana, West Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2002, 29: 511. PMID: 11981368, DOI: 10.1097/00042560-200204150-00012.Peer-Reviewed Original ResearchConceptsHIV seroprevalence ratesSeroprevalence ratesRisk factorsHIV-1HIV-2 seroprevalenceHIV-1 infectionHigh-risk populationCross-sectional studyHIV infectionHIV statusHIV-2Hospital outpatientsMultivariable modelPrenatal patientsDual infectionRisk populationsAnonymous studyInfectionRecord dataIntervention programsOutpatientsPatientsUrbanized communitiesSeroprevalenceHospitalHIV-1 and HIV-2 Seroprevalence and Risk Factors Among Hospital Outpatients in the Eastern Region of Ghana, West Africa
Chang L, OseiKwasi M, Boakye D, Aidoo S, Hagy A, Curran J, Vermund S. HIV-1 and HIV-2 Seroprevalence and Risk Factors Among Hospital Outpatients in the Eastern Region of Ghana, West Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2002, 29: 511-516. DOI: 10.1097/00126334-200204150-00012.Peer-Reviewed Original ResearchHIV seroprevalence ratesSeroprevalence ratesRisk factorsHIV-1HIV-2 seroprevalenceHIV-1 infectionHigh-risk populationCross-sectional studyHIV infectionHIV statusHIV-2Hospital outpatientsMultivariable modelPrenatal patientsDual infectionRisk populationsAnonymous studyInfectionRecord dataIntervention programsOutpatientsPatientsUrbanized communitiesSeroprevalenceHospital
1994
Prevention of HIV/AIDS with vaccines
Vermund S, Schultz A, Hoff R. Prevention of HIV/AIDS with vaccines. Current Opinion In Infectious Diseases 1994, 7: 82-94. DOI: 10.1097/00001432-199402000-00014.Peer-Reviewed Original ResearchHIV vaccineVaccine preparedness studyPhase II trialPhase III trialsHigh-risk populationHuman phase IViral envelope antigensHIV vaccine efficacyHigh behavioral riskLife-long infectionHIV/AIDSRecombinant subunit vaccinesEnvelope vaccinesHIV vaccinationII trialIII trialsClinical updateVaccine efficacyPreventive counselingEffective vaccineEfficacy trialsEnvelope antigenFirst vaccineTrial participantsLive vector
1988
Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population
Ritter D, Kadish A, Vermund S, Romney S, Villari D, Burk R. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. American Journal Of Obstetrics And Gynecology 1988, 159: 1517-1525. PMID: 2849881, DOI: 10.1016/0002-9378(88)90587-x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBiopsyCarcinoma, Squamous CellCervix UteriDNA, ViralFemaleForecastingHumansMiddle AgedPapanicolaou TestPapillomaviridaeRisk FactorsSensitivity and SpecificityTherapeutic IrrigationTumor Virus InfectionsUterine Cervical DiseasesUterine Cervical NeoplasmsVaginaVaginal SmearsConceptsHuman papillomavirus detectionHuman papillomavirus deoxyribonucleic acidHuman papillomavirus typesHuman papillomavirus type 16Cervical lesionsHuman papillomavirusPapillomavirus detectionPapillomavirus type 16Cervicovaginal lavageCytologic examinationPapillomavirus typesType 16Older womenHuman papillomavirus-negative womenPositive findingsCancerous lesionsAbnormal cytologic findingsHospital colposcopy clinicHuman papillomavirus infectionHigh-risk populationNegative cytologic resultsYears of ageHuman papillomavirus type 18Colposcopy clinicPapillomavirus infection